Heron Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$823K Sell
1,754
-40
-2% -$16.8K 0.44% 50
2023
Q1
$616K Sell
1,794
-100
-5% -$33.7K 0.34% 66
2022
Q4
$680K Hold
1,894
0.45% 49
2022
Q3
$612K Hold
1,894
0.38% 57
2022
Q2
$614K Sell
1,894
-20
-1% -$6K 0.37% 60
2022
Q1
$548K Hold
1,914
0.29% 76
2021
Q4
$475K Hold
1,914
0.26% 83
2021
Q3
$442K Hold
1,914
0.25% 85
2021
Q2
$439K Sell
1,914
-50
-3% -$10K 0.25% 87
2021
Q1
$364K Buy
1,964
+20
+1% +$3.91K 0.22% 93
2020
Q4
$322K Hold
1,944
0.22% 98
2020
Q3
$285K Sell
1,944
-330
-15% -$51.1K 0.23% 96
2020
Q2
$371K Sell
2,274
-100
-4% -$15.3K 0.33% 72
2020
Q1
$359K Buy
2,374
+100
+4% +$13.7K 0.37% 67
2019
Q4
$328K Buy
+2,274
New +$264K 0.27% 88

Other funds holding LLY

Heron Financial Group's LLY Position: Q2 2023 in Review

Heron Financial Group reduced its Eli Lilly (LLY) stake by 2.2% in Q2 2023, selling an estimated $16.8K and leaving 1,754 shares worth $823K. The position accounts for 0.44% of the portfolio, ranked #50.

Heron Financial Group first reported a position in LLY in Q4 2019 and has held it in 15 quarters since. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • Heron Financial Group held 1,754 shares of Eli Lilly worth $823K as of Q2 2023.
  • Heron Financial Group sold 40 Eli Lilly shares in Q2 2023, an estimated $16.8K.
  • Eli Lilly made up 0.44% of Heron Financial Group's portfolio in Q2 2023, its #50 holding.
  • Heron Financial Group first reported a position in Eli Lilly in Q4 2019 and has held it in 15 quarters since.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Heron Financial Group's 13F filing for Q2 2023, filed 10 Aug 2023.